A YEAR'S COMPARISON OF TREATMENT OF PATIENTS WITH PARKINSON'S DISEASE WITH LEVODOPA COMBINED WITH CARBIDOPA VERSUS TREATMENT WITH LEVODOPA ALONE
- 1 December 1973
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 302 (7844), 1459-1462
- https://doi.org/10.1016/s0140-6736(73)92729-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- DOPAMINE IN THE BASAL GANGLIA: Its Role and Therapeutic Implications (Including the Clinical Use of L-DOPA)British Medical Bulletin, 1973
- Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylaseJournal of Neurology, Neurosurgery & Psychiatry, 1973
- Methyldopahydrazine as an adjunct to L‐dopa therapy in parkinsonismNeurology, 1972
- Action of L‐α‐methyldopahydrazine on the blood pressure of patients receiving levodopaBritish Journal of Pharmacology, 1972
- Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitorJournal of Neurology, Neurosurgery & Psychiatry, 1971
- Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with LevodopaBMJ, 1971
- METABOLISM AND ABSORPTION OF l‐3,4 DIHYDROXYPHENYLALANINE IN PATIENTS WITH PARKINSON'S DISEASEAnnals of the New York Academy of Sciences, 1971
- LONG-TERM SIDE-EFFECTS OF LEVODOPAThe Lancet, 1971
- The metabolism of orally administered l‐DOPA in ParkinsonismBritish Journal of Pharmacology, 1969
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969